Related Experiment Video
Updated: Feb 5, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
Stroke incidence and anticoagulation treatment in patients with pacemaker-detected silent atrial fibrillation
Emma Sandgren1,2, Cecilia Rorsman1, Nils Edvardsson3
1Department of Medicine, Halland Hospital Varberg, Varberg, Sweden.
Insights
Silent atrial fibrillation (AF) is common, and anticoagulation may reduce stroke risk. Further research is needed to determine optimal treatment for patients with silent AF.
Area of Science:
- Cardiology
- Neurology
Background:
- Silent atrial fibrillation (AF) is prevalent, yet its optimal management, particularly anticoagulation, remains debated.
- Patients with pacemakers are at risk for developing silent AF.
Purpose of the Study:
- To investigate the incidence of silent AF in pacemaker patients.
- To assess the impact of anticoagulation on stroke and dementia risk in patients with and without AF.
Main Methods:
- Retrospective analysis of consecutive patients with dual-chamber pacemakers.
- Recording of silent AF development, anticoagulation status, and incidence of ischemic stroke and dementia.
Main Results:
- 30% of patients without known AF at implant developed silent AF during follow-up.
- Stroke incidence was similar in patients with known AF (2.1%) and silent AF (1.9%).
- Vascular dementia was more common in patients with known AF (11.2%) compared to those without AF (6.2%).
Conclusions:
- Anticoagulation may significantly reduce stroke risk in patients with silent AF.
- Vascular dementia risk is elevated in patients with known AF.
- More data is required to guide optimal anticoagulation strategies for silent AF.
Background:
Silent atrial fibrillation (AF) episodes are common but the role of anticoagulation treatment is under debate.
Methods:
Consecutive patients with dual-chamber pacemakers for sinus node disease or AV block/bundle branch block were retrospectively enrolled and the development of silent AF, any anticoagulation and the incidence of ischaemic stroke and dementia were recorded.
Results:
In total 411 patients without and 267 with known AF at implant were included. During a median follow-up of 38 months, 30% (125/411) of patients without known AF at implant were diagnosed with silent AF, 62% of those had or were prescribed anticoagulation. Heart failure (p = 0.03) and age >75 years (p = 0.0002) were risk markers for incident silent AF. In patients with known AF at implant, 80% (216/267) were on anticoagulation at implant. The annual stroke incidence was 2.1% in patients with known AF at implant, as compared to 1.9% in patients who developed silent AF during follow-up, and 1.4% in patients without AF. Vascular dementia developed in 11.2% and 6.2% respectively in patients with known AF versus no AF (p = 0.048) as well as in 5.6% of those with silent AF (p = 0.09).
Conclusion:
The stroke risk in our study population with an incident silent AF diagnosis may have been significantly decreased by the high proportion of anticoagulation treatment. This could imply that without this treatment the stroke risk might have been high enough to justify anticoagulation. Development of vascular dementia was twice as common among patients with known AF as compared to those witht silent AF or no AF. More data is needed to inform the optimal treatment for these patients.
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid Fibrils
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Prevalence and Incidence
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
Fibril-associated Collagen
For example, the type II collagen fibrils in cartilage have covalently bound type IX fibril-associated collagens at regular intervals. Other types of fibril-associated collagens are...
Types of Reports II: Incident or Occurrence Report
Purposes:
In the healthcare industry, reports play a crucial role in documenting incidents within an agency. The primary objective of these reports is to ensure patient safety, uphold the...

